Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Lowered to $9 at Cowen

August 7, 2019 11:14 AM
Cowen analyst Ken Cacciatore lowered the price target on Teva Pharma (NYSE: TEVA) to $9.00 (from $16.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles